The Human UDP-Glucuronosyltransferases: Structural Aspects and Drug Glucuronidation

References

• Antonio L., Grillasca J. P., Taskinen J., Elovaara E., Burchell B., Piet M. H., Ethell B., Ouzzine M., Fournel-Gigleux S., Magdalou J. Characterization of catechol glucuronidation in rat liver. Drug Metab. Dispos. 2002; 30: 199–207
   PubMed Web of Science ®Google Scholar
• Bailey M. J., Dickinson R. G. Acyl glucuronide reactivity in perspective: biological consequences. Chem. Biol. Interact. 2003; 145: 117–137
   PubMed Web of Science ®Google Scholar
• Bhasker C. R., McKinnon W., Stone A., Lo A. C., Kubota T., Ishizaki T., Miners J. O. Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance. Pharmacogenetics 2000; 10: 679–685
   PubMedGoogle Scholar
• Battaglia E., Pritchard M., Ouzzine M., Fournel-Gigleux S., Radominska A., Siest G., Magdalou J. Chemical modification of human UDP-glucuronosyltransferase UGT1*6 by diethylpyrocarbonate: possible involvement of a histidine residue in the catalytic process. Arch. Biochem. Biophys 1994a; 309: 266–272
   PubMed Web of Science ®Google Scholar
• Battaglia E., Senay C., Fournel-Gigleux S., Herber R., Siest G., Magdalou J. The chemical modification of human liver UDP-glucuronosyltransferase UGT1*6 reveals the involvement of a carboxyl group in catalysis. FEBS Lett. 1994b; 346: 146–150
   PubMed Web of Science ®Google Scholar
• Bossuyt X., Blanckaert N. Differential regulation of UDP-GlcUA transport in endoplasmic reticulum and in golgi membranes. J. Hepatol. 2001; 34: 210–214
   PubMed Web of Science ®Google Scholar
• Campbell J. A., Davies G. J., Bulone V., Henrissat B. A classification of nucleotide-diphospho-sugar glycosyltransferases based on amino acid sequence similarities. Biochem. J. 1997; 326: 929–939
   PubMedGoogle Scholar
• Ciotti M., Marrone A., Potter C., Owens I. S. Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics 1997; 7: 485–495
   PubMedGoogle Scholar
• Ciotti M., Cho J. W., George J., Owens I. S. Required buried alpha-helical structure in the bilirubin UDP-glucuronosyltransferase, UGT1A1, contains a nonreplaceable phenylalanine. Biochemistry 1998; 37: 11018–11025
   PubMed Web of Science ®Google Scholar
• Coffman B. L., Kearney W. R., Green M. D., Lowery R. G., Tephly T. R. Analysis of opioid binding to UDP-glucuronosyltransferase UGT2B7 fusion proteins using nuclear magnetic resonance spectroscopy. Mol. Pharmacol. 2001; 59: 1464–1469
   PubMed Web of Science ®Google Scholar
• Coffman B. L., Kearney W. R., Goldsmith S., Knosp B. M., Tephly T. R. Opioids bind to the aminoacid 84 to 118 of UDP-glucuronosyltransferase UGT2B7. Mol. Pharmacol. 2003; 63: 283–288
   PubMed Web of Science ®Google Scholar
• Court M. H., Duan S. X., Guillemette C., Journault K., Krishnaswamy S., Von Moltke L. L., Greenblatt D. J. Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs):S -oxazepam is glucuronidated by UGT2B15, whileR -oxazepam is glucuronidated by UGT2B7 and UGT1A9. Drug Metab. Dispos. 2002; 30: 1257–1265
   PubMed Web of Science ®Google Scholar
• Dubois S. G., Beaulieu M., Levesque E., Hum D. W., Belanger A. Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution. J. Mol. Biol. 1999; 289: 29–39
   PubMed Web of Science ®Google Scholar
• Duvaldestin P., Mahu J. L., Preaux A. M., Berthelot P. Novobiocin-inhibition and magnesium-inetraction of rat liver microsomal bilirubin UDP-glucuronosyltransferase. Biochem. Pharmacol. 1976; 25: 2587–2592
   PubMed Web of Science ®Google Scholar
• Fournel-Gigleux S., Sutherland L., Sabolovic N., Burchell B., Siest G. Stable expression of two human UDP-glucuronosyltransferase cDNAs in V79 cell cultures. Mol. Pharmacol. 1991; 39: 177–183
   PubMed Web of Science ®Google Scholar
• Ghosh S. S., Sappal B. S., Kalpana G. V., Lee S. W., Chowdhury J. R., Chowdhury N. R. Homodimerization of human bilirubin-uridine-diphosphoglucuronate glucuronosyltransferase-1 (UGT1A1) and its functional implications. J. Biol. Chem. 2001; 276: 42108–42115
   PubMed Web of Science ®Google Scholar
• Grancharov K., Naydenova Z., Lozeva S., Golovinsky E. Natural and synthetic inhibitors of UDP-glucuronosyltransferase. Pharm. Ther. 2001; 89: 171–186
   PubMed Web of Science ®Google Scholar
• Gschaidmeier H., Bock K. W. Radiation inactivation analysis of microsomal UDP-glucuronosyltransferases catalyzing mono- and diglucuronide formation of 3,6-dihydroxybenzo(a)pyrene and 3,6-dihydroxychrysene. Biochem. Pharmacol. 1994; 48: 1545–1549
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Parikh A., Johnson E. F., Richardson T. H., von Wachenfeldt C., Cosme J., Jung F., Strassburg C. P., Manns M. P., Tukey R. H., Pritchard M., Fournel-Gigleux S., Burchell B. Heterologous expression of human drug-metabolizing enzymes. Drug Metab. Dispos. 1997; 25: 1234–1241
   PubMed Web of Science ®Google Scholar
• Guillemette C., Villeneuve L. Substrate-dependant impact of a novel exon 1 polymorphism in the human UGT1A9 gene. Drug Metab. Rev. 2003; 35(suppl 1)59
   Google Scholar
• Guillemette C., Ritter J. K., Auyeung D. J., Kessler F. K., Housman D. E. Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 2000; 10: 629–644
   PubMedGoogle Scholar
• Herber R., Hercelin B., van Cantford J., De Graeve J., Fournel-Gigleux S., Tagushi T., Magdalou J. Reduction and glucuronidation of naftazone by human and rat liver microsomes. Drug Metab. Dispos. 1995; 23: 1305–1314
   PubMed Web of Science ®Google Scholar
• Huang Y. H., Galijatovic A., Nguyen N., Geske D., Beaton D., Green J., Green M., Peters W. H., Tukey R. H. Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3. Pharmacogenetics 2002; 12: 287–297
   PubMedGoogle Scholar
• Ikushiro S., Emi Y., Iyanagi T. Protein–protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes. Biochemistry 1997; 36: 7154–7161
   PubMed Web of Science ®Google Scholar
• Ikushiro S., Emi Y., Kimura S., Iyanagi T. Chemical modification of rat hepatic microsomes withN -ethylmaleimide results in inactivation of both UDP-N -acetylglucosamine-dependent stimulation of glucuronidation and UDP-GlcUA uptake. Biochim. Biophys. Acta 1999; 1428: 388–396
   PubMed Web of Science ®Google Scholar
• Ikushiro S., Emi Y., Iyanagi T. Activation of glucuronidation through a disulfide bond in rat UDP-glucuronosyltransferase 1A6. Biochemistry 2002; 41: 12813–12820
   PubMed Web of Science ®Google Scholar
• Ikushiro S., Murakami Y., Emi Y., Iyanagi T. Hetero-oligomeric interaction between UDP-glucuronosyltransferase (UGT) isozymes and hepatic microsomes. Drug Metab. Rev. 2003; 35(suppl 1)58
   Google Scholar
• Ishii Y., Miyoshi A., Watanabe R., Tsuruda K., Tsuda M., Yamaguchi-Nagamatsu Y., Yoshisue K., Tanaka M., Maji D., Ohgiya S., Oguri K. Simultaneous expression of guinea pig UDP-glucuronosyltransferase 2B21 and 2B22 in COS-7 cells enhances UDP-glucuronosyltransferase 2B21-catalyzed morphine-6-glucuronide formation. Mol. Pharmacol. 2001; 60: 1040–1048
   PubMed Web of Science ®Google Scholar
• Iwano H., Yokota H., Ohgiya S., Yuasa A. The significance of amino acid residue Asp-446 for enzymatic stability of rat UDP-glucuronosyltransferase UGT1A6. Arch. Biochem. Biophys. 1999; 363: 116–120
   PubMed Web of Science ®Google Scholar
• Jackson M. R., Fournel-Gigleux S., Harding D., Burchell B. Examination of the substrate specificity of cloned rat kidney phenol UDP-glucuronosyltransferase expressed in COS-7 cells. Mol. Pharm. 1998; 34: 638–642
   Google Scholar
• Jin C. J., Miners J. O., Lillywhite K. J., Mackenzie P. I. cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily. Biochem. Biophys. Res. Commun. 1993; 194: 496–503
   PubMed Web of Science ®Google Scholar
• King C. D., Rios G. R., Assouline J. A., Tephly T. R. Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate. Arch. Biochem. Biophys. 1999; 365: 156–162
   PubMed Web of Science ®Google Scholar
• Koiwai O., Aono S., Adachi Y., Kamisako T., Yasuil Y., Nishizawa M., Sato H. Crigler-Najjar syndrome type II is inherited both as a dominant and as a recessive trait. Hum. Mol. Genet. 1996; 5: 645–647
   PubMed Web of Science ®Google Scholar
• Kurkela M., Garcia-Horsman A., Luukkanen L., Mörsky S., Taskinen J., Baumann M., Kostiainen R., Hirvonen J., Finel M. Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs); UGT1A9 is more resistant to detergent inhibition than the other UGTs, and was purified as an active dimeric enzyme. J. Biol. Chem. 2003; 278: 3536–3544
   PubMed Web of Science ®Google Scholar
• Levesque E., Beaulieu M., Hum D. W., Belanger A. Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 1999; 9: 207–216
   PubMedGoogle Scholar
• Mackenzie P. I. Expression of chimeric cDNAs in cell culture defines a region of UDP glucuronosyltransferase involved in substrate selection. J. Biol. Chem. 1990; 265: 3432–3435
   PubMed Web of Science ®Google Scholar
• Mackenzie P. I., Owens I. S., Burchell B., Bock K. W., Bairoch A., Belanger A., Fournel-Gigleux S., Green M., Hum D. W., Iyanagi T., Lancet D., Louisot P., Magdalou J., Roy-Chowdhury J., Ritter J. K., Schachter H., Tephly T. R., Tipton K. K., Nebert D. W. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 1997; 7: 255–269
   PubMedGoogle Scholar
• Matern H., Matern S., Gerok W. Isolation and characterization of rat liver microsomal UDP-glucuronosyltransferase activity toward chenodeoxycholic acid and testosterone as a single form of enzyme. J. Biol. Chem. 1982; 257: 7422–7429
   PubMed Web of Science ®Google Scholar
• Meech R., Mackenzie P. I. UDP-glucuronosyltransferase, the role of amino acid terminus in dimerization. J. Biol. Chem. 1997; 272: 26913–26917
   PubMed Web of Science ®Google Scholar
• Meech R., Mackenzie P. I. Determinants of UDP glucuronosyltransferase membrane association and residency in the endoplasmic reticulum. Arch. Biochem. Biophys. 1998; 356: 77–85
   PubMed Web of Science ®Google Scholar
• Meech R., Yogalingam G., Mackenzie P. I. Mutational analysis of the carboxy-terminal region of UDP-glucuronosyltransferase 2B1. DNA Cell Biol. 1996; 15: 489–494
   PubMed Web of Science ®Google Scholar
• Monaghan G., Ryan M., Seddon R., Hume R., Burchell B. Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 1996; 347: 578–581
   PubMed Web of Science ®Google Scholar
• Muraoka M., Kawakita M., Ishida N. Molecular characterization of human UDP-glucuronic acid/UDP-N -acetylgalactosamine transporter, a novel nucleotide sugar transporter with dual substrate specificity. FEBS Lett. 2001; 495: 87–93
   PubMed Web of Science ®Google Scholar
• Ouzzine M., Magdalou J., Burchell B., Fournel-Gigleux S. An internal signal sequence mediates the targeting and retention of the human UDP-glucuronosyltransferase 1A6 to the endoplasmic reticulum. J. Biol. Chem. 1999a; 274: 31401–31409
   PubMed Web of Science ®Google Scholar
• Ouzzine M., Magdalou J., Burchell B., Fournel-Gigleux S. Expression of a functionally active human hepatic UDP-glucuronosyltransferase (UGT1A6) lacking the N-terminal signal sequence in the endoplasmic reticulum. FEBS Lett. 1999b; 45: 4187–4191
   Google Scholar
• Ouzzine M., Antonio L., Burchell B., Netter P., Fournel-Gigleux S., Magdalou J. Importance of histidine residues for the function of the human liver UDP-glucuronosyltransferase UGT1A6: evidence for the catalytic role of histidine 370. Mol. Pharmacol. 2000; 58: 1609–1615
   PubMed Web of Science ®Google Scholar
• Peters W. H., Jansen P. L., Nauta H. The molecular weights of UDP-glucuronyltransferase determined with radiation-inactivation analysis. A molecular model of bilirubin UDP-glucuronyltransferase. J. Biol. Chem. 1984; 259: 11701–11705
   PubMed Web of Science ®Google Scholar
• Pillot T., Ouzzine M., Fournel-Gigleux S., Lafaurie C., Tebbi D., Treat S., Radominska A., Lester R., Siest G., Magdalou J. Determination of the human liver UDP-glucuronosyltransferase 2B4 domains involved in the binding of UDP-glucuronic acid using photoaffinity labeling of fusion proteins. Biochem. Biophys. Res. Commun. 1993; 197: 785–791
   PubMed Web of Science ®Google Scholar
• Pritchard M., Fournel-Gigleux S., Siest G., Mackenzie P., Magdalou J. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1 stabily expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids. Mol. Pharmacol. 1994; 45: 42–50
   PubMed Web of Science ®Google Scholar
• Radominska-Pandya A., Czernik P. J., Little J. M., Battaglia E., Mackenzie P. I. Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab. Rev. 1999; 31: 817–899
   PubMed Web of Science ®Google Scholar
• Senay C., Ouzzine M., Battaglia E., Pless D., Cano V., Burchell B., Radominska A., Magdalou J., Fournel-Gigleux S. Arginine 52 and histidine 54 located in a conserved N-terminal hydrophobic region (LX2-R 52 -G-, H 54 -X3-V-L) are important amino acids for the functional and structural integrity of the human liver UDP-glucuronosyltransferase UGT1*6. Mol. Pharmacol. 1997; 51: 406–413
   PubMed Web of Science ®Google Scholar
• Senay C., Jedlitschky G., Terrier N., Burchell B., Magdalou J., Fournel-Gigleux S. The importance of cysteine 126 in the human liver UDP-glucuronosyltransferase UGT1A6. Biochim. Biophys. Acta 2002; 1597: 90–96
   PubMed Web of Science ®Google Scholar
• Shepherd S. R., Baird S. J., Hallinan T., Burchell B. An investigation of the transverse topology of bilirubin UDP-glucuronosyltransferase in rat hepatic endoplasmic reticulum. Biochem. J. 1989; 259: 617–620
   PubMed Web of Science ®Google Scholar
• Sorich M. J., Smith P. A., McKinnon R. A., Miners J. O. Pharmacophore and quantitative structure activity relationship modelling of UDP-glucuronosyltransferase 1A1 (UGT1A1) substrates. Pharmacogenetics 2002; 12: 635–645
   PubMedGoogle Scholar
• Takenaga N., Ishii M., Kamei T., Yasumori T. Structure-activity relationship inO -glucuronidation of indolcarbazole analogs. Drug Metab. Dispos. 2002; 30: 494–497
   PubMed Web of Science ®Google Scholar
• Tukey R. H., Strassburg C. P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol. 2000; 40: 581–616
   PubMed Web of Science ®Google Scholar
• Tukey R. H., Strassburg C. P., Mackenzie P. I. Pharmacogenomics of human UDP-glucuronosyltransferases and irinotecan toxicity. Mol. Pharmacol. 2002; 62: 446–450
   PubMed Web of Science ®Google Scholar
• Zenser T. V., Lakshmi V. M., Fu Hsu F., Davis B. B. Metabolism ofN -acylbenzidine and initiation of bladder cancer. Mutation Res. 2002; 506–507, 29–40
   Google Scholar